The overall aim of this project is to develop a novel integrated suite of software applications for predicting, refining and manipulating biomacromolecular structure, particularly with respect to computational virtual screening of drug candidates. Virtual screening of a panel of ligands against a biomacromolecule target requires a highly accurate model for the ligand binding site, as well as rapid and effective estimation of binding affinity. In many important drug discovery projects both of these requirements cannot be met. The two main goals of the proposed research are thus to: 1) improve the accuracy and relability of free energy scoring of putative protein-ligand complexes, and 2) enhance the quality of low-resolution structural models from x-ray, nmr or comparative modeling to make them useful as targets for virtual screening. The core technology for this research plan is based on the HINT (Hydropathic INTeractions) program/paradigm that exports (with reasonable speed and accuracy) both a unique empirical free energy forcefield and threedimensional graphics objects that encode significant structural information. A number of specific software tools will be created by this effort: a) an integrated docking system using HINT forcefield scoring;b) an automated computational titration program that evaluates the ionization state of residues and ligand functional groups to optimize ligand binding;c) a range of methods to predict and/or optimize water molecule locations in environments where water-mediated hydrogen bonding could impact ligand binding;d) a new de novo ligand design protocol based on three-dimensional hydropathy maps;and e) integrated crystallographic and NMR refinement program(s) using the hydropathic forcefield as a target function. This latter tool may be extended as an adjunct to homology modeling approaches to creating target structures, and may prove useful for defining models of inaccessible proteins. Specific collaborative arrangements are in place to apply these tools to a range of current drug discovery problems.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM071894-05
Application #
7587410
Study Section
Special Emphasis Panel (ZRG1-BDMA (01))
Program Officer
Okita, Richard T
Project Start
2005-04-01
Project End
2011-03-31
Budget Start
2009-04-01
Budget End
2011-03-31
Support Year
5
Fiscal Year
2009
Total Cost
$204,855
Indirect Cost
Name
Virginia Commonwealth University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Sarkar, Aurijit; Anderson, Kelcey C; Kellogg, Glen E (2012) Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics. Eur J Med Chem 52:98-110
Kuchta, Alison L; Parikh, Hardik; Zhu, Yali et al. (2012) Structural modelling and mutagenesis of human cytomegalovirus alkaline nuclease UL98. J Gen Virol 93:130-8
Koparde, Vishal N; Scarsdale, J Neel; Kellogg, Glen E (2011) Applying an empirical hydropathic forcefield in refinement may improve low-resolution protein X-ray crystal structures. PLoS One 6:e15920
Ahmed, Mostafa H; Spyrakis, Francesca; Cozzini, Pietro et al. (2011) Bound water at protein-protein interfaces: partners, roles and hydrophobic bubbles as a conserved motif. PLoS One 6:e24712
Bayden, Alexander S; Yakovlev, Vasily A; Graves, Paul R et al. (2011) Factors influencing protein tyrosine nitration--structure-based predictive models. Free Radic Biol Med 50:749-62
Sarkar, Aurijit; Kellogg, Glen E (2010) Hydrophobicity--shake flasks, protein folding and drug discovery. Curr Top Med Chem 10:67-83
Salsi, Enea; Bayden, Alexander S; Spyrakis, Francesca et al. (2010) Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature. J Med Chem 53:345-56
Tripathi, Ashutosh; Kellogg, Glen E (2010) A novel and efficient tool for locating and characterizing protein cavities and binding sites. Proteins 78:825-42
Yakovlev, Vasily A; Bayden, Alexander S; Graves, Paul R et al. (2010) Nitration of the tumor suppressor protein p53 at tyrosine 327 promotes p53 oligomerization and activation. Biochemistry 49:5331-9
Tripathi, Ashutosh; Durrant, David; Lee, Ray M et al. (2009) Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity. J Enzyme Inhib Med Chem 24:1237-44

Showing the most recent 10 out of 23 publications